Q4 2025 earnings call recap: results, $1.4B impairment, segment trends, and 2026 guidance for revenue, margins & FCF—read now.
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat ® KMT2A + MRD Assay and Software to its industry-leading ...
Over the last several decades, urban planners and municipalities have sought to identify and better manage the socioeconomic ...
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced it has submitted a 510(k) premarket ...
The Texas State Board of Education voted 9-4 last week to add the conservative-championed Classic Learning Test to a narrow ...
QTRX submits a 510(k) to the FDA for its multi-analyte blood test aimed at evaluating cognitive symptoms for possible ...
Munich, GermanyFollowing exceptional user retention rates in Europe’s most rigorous financial market, Gainorex ...
The new Fed Chair nominee can't shrink the balance sheet without handing private markets a duration problem they may not want ...
Solid-state battery developer QuantumScape is off and running in 2026, inaugurating its shiny new Eagle Line for pilot production.
COVID and flu tests aren't designed to tell you how sick you are, but if you use them to monitor your infection, they can ...
Brian Ferdinand serves as a Strategic Advisor to Helix Alpha, providing market insight and execution-oriented perspective to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results